Toru Kondo

6PUBLICATIONS
2CO-AUTHORS
BiofabricationGene and molecular therapyGene expression (incl. microarray and other genome-wide approaches)Molecular targetsRegenerative medicine (incl. stem cells)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Jun 30, 2026
Carboxy terminal of ECRG4 is a potential initiator for amyloid pathology in Alzheimer's disease through interacting with APP intracellular domain.

|Mar 27, 2026
Neuronal Differentiation of GBM-Initiating Cells Combined with Elimination of Undifferentiated Cells Preserves Motor Function.

Zhenzhong Chen, Peilin Zou, Toru Kondo

|Apr 11, 2025
Novel strategy to target glioblastoma-initiating cells using a braintropic adeno-associated virus carrying a miR-dependent genome-editing system.

Zhe Wang, Peilin Zou, Zhenzhong Chen

|Oct 29, 2024
EVA1-antibody drug conjugate is a new therapeutic strategy for eliminating glioblastoma-initiating cells.

Jiahui Hou, Tamami Uejima, Miho Tanaka

|Oct 10, 2020
Selective eradication of pluripotent stem cells by inhibiting DHODH activity.

Toru Kondo

|Feb 13, 2019
Ecrg4 deficiency extends the replicative capacity of neural stem cells in a Foxg1-dependent manner.

Yuka Nakatani, Hiroshi Kiyonari, Toru Kondo

Pageof 1

Frequent Collaborators

1 joint publications

Zhenzhong Chen

1 joint publications

Michael Lai Kit Chung